MedPath

Vitamin D Treatment for Crohn´s Disease

Phase 2
Conditions
Crohns Disease
Registration Number
NCT00132184
Lead Sponsor
University of Aarhus
Brief Summary

The purpose of this study is to examine whether vitamin D treatment is effective in Crohn's disease.

Detailed Description

Crohns Disease is an inflammatory disease of primarily the small intestine and colon.

In recent years scientists have hypothesized that low blood vitamin-D levels play a role in the development of autoimmune diseases, including Crohns disease. The purpose of this study is to examine whether vitamin-D is effective in keeping remission in inactive Crohns Disease (double blind placebo controlled trial). The patients who have active disease in the placebo group (reach primary endpoint), will in an open setting receive a higher single dose vitamin-D and the effect will be measured within 4 weeks.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
110
Inclusion Criteria
  • Crohn's disease
  • Inactive Crohn's disease for at least 4 weeks
  • Crohn's Disease Activity Index (CDAI) < 150
  • C-reactive protein within normal range
  • Serum albumin within normal range
Read More
Exclusion Criteria
  • Hypercalcemia
  • Short bowel syndrome
  • Pregnancy
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Relapse rate within 1 year treatment; CDAI>220
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Aarhus University Hospital, Department V

🇩🇰

Aarhus, Denmark

Hospital of Horsens

🇩🇰

Horsens, Denmark

Hospital of Randers

🇩🇰

Randers, Denmark

Hospital of Silkeborg

🇩🇰

Silkeborg, Denmark

© Copyright 2025. All Rights Reserved by MedPath